Detected ·
mbiomics GmbH
——
Munich-based TechBio company mbiomics GmbH announced the third closing of its Series A funding round in late April, bringing the total round to €30M. The company develops microbiome-based therapeutics using live bacterial strains.
- Website
- www.mbiomics.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-26 12:12:21 UTC
- Signal ID
- e3310ba8-8543-4a08-bf8d-edf503e536d8
As the API returns it
{
"id": "e3310ba8-8543-4a08-bf8d-edf503e536d8",
"created_at": "2026-05-26T12:12:21.504410Z",
"company_name": "mbiomics GmbH",
"company_website_url": "www.mbiomics.com",
"company_linkedin_url": "https://www.linkedin.com/company/mbiomics-gmbh",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Munich-based TechBio company mbiomics GmbH announced the third closing of its Series A funding round in late April, bringing the total round to €30M. The company develops microbiome-based therapeutics using live bacterial strains.*"
}